Clinical Report: Withdrawal of Study on Exosome Component 4 in EOC

Overview

The article discussing Exosome Component 4's role in enhancing proliferation, migration, and invasion of epithelial ovarian cancer cells has been retracted due to concerns regarding image integrity.

Background

Epithelial ovarian cancer (EOC) is often diagnosed at advanced stages. Concerns were raised regarding the integrity of the research findings related to EOC progression.

Data Highlights

No numerical or trial data is available due to the retraction of the study.

Key Findings

• The original study claimed that Exosome Component 4 promotes EOC cell proliferation, migration, and invasion via the Wnt pathway.
• Concerns were raised regarding image integrity in the published figures, particularly in Figure 2A.
• The authors did not provide a satisfactory explanation during the investigation into these concerns.
• The article has been officially retracted by the Chief Editors of Frontiers in Oncology.
• The retraction was communicated to the authors, who had the opportunity to respond.

Clinical Implications

The retraction of this study emphasizes the importance of data integrity in cancer research.

Conclusion

The retraction of the study on Exosome Component 4 underscores the necessity for maintaining high standards of research integrity in oncology.

Related Resources & Content

1. Frontiers Editorial Office, Frontiers in Oncology, 2026 -- Retraction: Exosome component 4 promotes epithelial ovarian cancer cell proliferation, migration, and invasion via the Wnt pathway
2. The ASCO Post — Role of Epithelial-to-Mesenchymal Transition in Ovarian Cancer
3. The ASCO Post — Gab2 Promotes Characteristics of Epithelial-to-Mesenchymal Transition in Ovarian Cancer
4. Gastric Cancer — Exosome-Dependent Role of CD97 in Promoting Lymphatic Metastasis of Gastric Carcinoma
5. Frontiers in Oncology — Effects of SOX10 on the proliferative, invasive, migratory, and epithelial–mesenchymal transition abilities of triple-negative breast cancer cells
6. Role of Epithelial-to-Mesenchymal Transition in Ovarian Cancer
7. Gab2 Promotes Characteristics of Epithelial-to-Mesenchymal Transition in Ovarian Cancer
8. Exosome-Dependent Role of CD97 in Promoting Lymphatic Metastasis of Gastric Carcinoma
9. Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
10. Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer